Click here for YNHH home page.

Sign up for HealthLINK.

Can we help?

Follow up on this month's He@lthLINK

 


Phone Numbers

Directory assistance
(203) 688-4242

Patient information
(203) 688-4177

Adult emergency
(203) 688-2222

Children's emergency
(203) 688-3333

Admitting
(203) 688-2221

Children's admitting
(203) 688-3331



Mailing address:
Yale-New Haven Hospital
20 York Street
New Haven, CT
06510-3202





Yale-New Haven Hospital, New Haven, Connecticut, USA HealthLINK: Women's Health
September 3, 1999

News this month
First guidelines for diagnosis and treatment of osteoporosis released

Osteoporosis is a silent risk factor for fracture, just as high blood pressure is for stroke, but all too often a fracture is the first indication that a person's bones have become dangerously weakened.

It doesn't have to be that way according to guidelines issued recently by the National Osteoporosis Foundation (NOF) in collaboration with 10 multidisciplinary medical organizations. It is now possible to determine a person's propensity for fracture earlier and to offer preventive treatments for most people at risk of developing the disease.

It is now possible to determine a person’s propensity for fracture earlier and to offer preventive treatments for most people at risk of developing osteoporosis.

The NOF released “urgent new and aggressive guidelines” for the treatment of the 28 million Americans, mostly women, who suffer from the disease. All postmenopausal women should be considered for osteoporosis treatment, the NOF said, since up to half of all white women age 50 and older can expect to have a fracture because of osteoporosis.

“Prevention, detection and treatment of osteoporosis should be a mandate of primary care, and a routine part of physicals,” said Dr. Robert Lindsay, foundation president.

A bone mineral density test (BMD) is the only way to determine bone health, and the foundation recommends the X-ray-like test, which is quick and painless, for women past menopause, particularly those 65 and older, who have had a bone fracture and those with one or more risk factors for an osteoporosis-related fracture.

Who should be tested?
The foundation recommends a BMD test for:
  • All women 65 and older, regardless of other risk factors. Medicare now reimburses for the tests in eligible women.
  • All women past menopause who have had a fracture, including the vertebral fractures that cause a shortening and hunching of the spine.
  • Women past menopause who have any risk factor for suffering an osteoporotic fracture.

Osteoporosis risk factors

  • A personal history of fracture as an adult, regardless of what caused it.
  • A history of fracture in a parent or sibling.
  • Cigarette smoking.
  • A small, thin frame, defined by a body weight of less than 127 pounds.

There is a much longer list of risk factors considered secondary because they may be less common or less well documented. But they are no less important. Nonmodifiable factors include being of the Caucasian race, advanced in age, frail or in poor health or suffering from dementia.

Modifiable risk factors include having a diet low in calcium, having an eating disorder (anorexia or bulimia) and being estrogen-deficient (including having undergone menopause before age 45 or having gone more than a year without menstrual periods other than because of pregnancy).

Risk factors you can modify:

  • diet low in calcium
  • eating disorder
  • estrogen deficiency

The foundation also recommends testing for women who have been on hormone replacement for many years, a suggestion that may seem strange because estrogen after menopause protects the bones. However, Dr. Lindsay explained that “many women are inconsistent in their use of hormones. They periodically stop taking them–and doctors should not assume that women on hormone replacement are not osteoporotic.”

Test results
BMD test results are evaluated by comparing the density of the patient’s bones with that of a young, normal adult–usually a 35-year-old woman. The test results are measured in standard deviations and one unit below normal is equivalent to a 10 to 12 percent decrease in bone density and is considered healthy.
With measurements between 1 and 2.5 units below normal, bone mass is low and at serious risk of becoming osteoporotic, and at 2.5 units or more below normal, the diagnosis is osteoporosis.

Several medications are available to treat osteoporosis. The foundation recommends treatment for women with no risk factors and a score of 2.5 or below and for women with risk factors and a score at 1.5 or below.

All men and women should consume adequate amounts of calcium and vitamin D; get regular weight-bearing exercise and avoid tobacco use and abuse of alcohol.

Prevention
While it is never too late to slow bone loss and even improve bone density, the sooner preventive treatment is started, the better. The guidelines suggest that all men and women consume adequate amounts of calcium and vitamin D (at least 1,200 milligrams of calcium and 400 to 800 international units of vitamin D daily); get regular weight-bearing exercise such as walking, jogging, stair climbing, dancing and tennis and avoid tobacco use and abuse of alcohol.

Yale-New Haven Hospital offers Bone Mineral Density (BMD) scans read by accredited radiologists. Ask your doctor for a referral.





Physician Referral Online

A free and confidential service
of Yale-New Haven Hospital.

Physician Referral Online
Using your own criteria, you can request information from a database of 900 area physicians who have registered to participate.

Request an appointment
We would be happy to assist you in scheduling an appointment with a member of the hospital's medical staff. Use the link above or call:

203-688-2000
or toll free
1-888-700-6543
to talk with a referral coordinator.



Adina Chelouche, M.D.

A fresh look at osteoporosis

When you think about it, it's unbelievable that until a few months ago there were no comprehensive guidelines for evaluating and treating osteoporosis, which is estimated to affect more than 25 million women in this country.

An ounce of prevention
When I talk with my younger patients, I focus on what they can do to prevent the disease: making sure they get adequate calcium in their diet and engage in weight-bearing exercise. We recommend the amount suggested by the NOF, 1,200 milligrams of calcium each day. All milk and milk products are calcium powerhouses. A cup of skim milk contains about 300 milligrams of calcium. At 80 calories a cup, skim milk is a calcium bargain and actually has fewer calories than a cup of apple juice.

“Skim milk is a calcium bargain and actually has fewer calories than a cup of apple juice.”

Plain yogurt provides 450 mg of calcium per cup, and flavored yogurt provides about 250 mg to 300 mg a cup. Frozen yogurt also contains calcium, but it costs in the calorie department. You would have to eat more than two cups of most premium brand frozen yogurts at a total of 585 calories, to get the same amount of calcium as in a cup of plain yogurt, at a mere 125 calories.

Diet supplements
Calcium supplements are widely available. There are two basic kinds: calcium carbonate, which can be refined from limestone or may come from shell sources, usually oysters, and calcium citrate. Calcium citrate tends to be absorbed more readily, but it is more expensive. There are some concerns the shell-based variety of calcium carbonate may contain lead contamination.

Vitamin D is important too since it helps the body to absorb calcium. Most women don’t need to take Vitamin D supplements since normal exposure to sunlight provides an ample amount, but for women who may be confined indoors, a multiple vitamin containing between 400 to 800 IU of vitamin D is beneficial.

“Caffeine interferes with calcium absorption….and cigarette smoking is also detrimental to bone.”

Coffee drinkers take note: Caffeine interferes with calcium absorption, so pay extra attention to your calcium intake if you drink a lot of caffeinated beverages. And cigarette smoking, among its other ill effects, is also detrimental to bone.

Exercise builds bone
Weight-bearing exercise builds bone whatever your age, but whole-body exercise like walking, jogging, tennis, etc. is particularly important for women in their prime bone-building years--between 25 and 35. The higher your peak bone mass, the more bone you have “in the bank” and the less likely you'll be to develop osteoporosis as you lose bone during normal aging.

Too much of anything may be harmful, and that’s true of exercise too. Women who engage in intense, sustained physical exercise may stop having periods. Their ovaries stop producing estrogen and a lack of estrogen is a prime risk factor for osteoporosis.

Estrogen deficits
Any condition that results in lower estrogen puts women at risk for osteoporosis, including:

  • Menopause: Women experience a relatively sudden drop in production of estrogen at menopause and start losing bone at an accelerated rate. For the first five to eight years after menopause, women may lose as much as 5 percent of their bone mass each year.
  • The use of certain nonestrogenic birth control medications such as the long-acting progesterone, Depo-Provera®, stops the body’s own production of estrogen without replacing it. Normal oral contraceptives have a positive effect on bone.
  • Long-term use of corticosteroid medications, such as prednisone, cortisone, prednisolone and dexamethasone, is very damaging to bone. These medications are important treatments for chronic conditions, such as asthma, rheumatoid arthritis and psoriasis. If you need to take steroid medications for long periods, your doctor may monitor your bone density and advise other drugs to help prevent bone loss.
  • Too much thyroid hormone can also cause bone loss. This condition can occur when your thyroid is overactive (hyperthyroidism) or when you take excessive thyroid hormone medication to treat an underactive thyroid (hypothyroidism).

Other risk factors
As the NOF guidelines outline, other osteoporosis risk factors include smoking, Caucasian race, small build, having a sister or mother with the disease, losing an inch or more of height and poor nutrition.

First line of prevention and treatment
Estrogen replacement therapy (ERT) is the single most important way to reduce a woman's risk of osteoporosis during and after menopause. It can prevent bone loss and reduce risk of spine and hip fractures by about 50 percent. ERT can prevent bone loss any time after menopause, but generally the earlier a woman starts the therapy, the more bone she'll retain.

“As soon as estrogen is stopped, bone loss starts again.”

The therapy can be continued indefinitely. Long term use–the longer, the better–provides the best protection against bone loss. As soon as estrogen is stopped, bone loss starts again.

Drugs that slow bone loss
Estrogen replacement therapy is not only the best way to prevent osteoporosis in women, it's also the best way to treat the disease. But if you can't or don't want to take estrogen, two prescription drugs can help slow bone loss and may even increase bone density over time.

  • Bisphosphonates, the newest and best known of these drugs is alendronate (Fosamax®). Studies show it can reduce risk of hip and spine fractures by about 50 percent. Alendronate is generally safe if taken properly, but can produce nausea, abdominal pain and more serious side effects if taken improperly.
  • Calcitonin, a hormone produced in the thyroid, may slow bone loss and prevent spine fractures. The drug can also reduce pain after a fracture. Calcitonin is usually used to treat people with osteoporosis who are at high risk for fracture and can't take estrogen or bisphosphonates. The drug is available as an injection or a nasal spray.

Bone scans
In our practice, we usually do not recommend bone mineral density testing if a woman is already taking estrogen replacement therapy. If a patient is menopausal and is undecided about hormone replacement therapy, a test can be helpful to determine if ERT should be considered as an osteoporosis prevention therapy.

BMDs are essential for women age 50 and older who are not on estrogen replacement therapy and who have had bone fractures or who are at high risk for osteoporosis. BMDs are very effective diagnostic tests and women who are evaluated as losing significant bone mass can benefit from new, recently approved medications.


Dr. Chelouche is an attending obstetrician/gynecologist at Yale-New Haven Hospital and a partner of the County Obstetrics and Gynecology Group with offices in New Haven, Branford, Clinton and Wallingford.


Spacer.
Subscribe to HealthLink.

 

Other related links.

Copyright 1999-2010.
Top of Page. Y-NHH. YNHHS. Site Editor.

Home page
Staff directory
Directions and parking
Online resources
Yale New Haven Health System
  Need a doctor?
Search
Comments
Top of page
Yale-New Haven Medical Center